Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Mirtazapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 4 Anorexia 4 Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Cachexia 2 Breast Neoplasms 2 Weight Loss 1 Neoplasm Metastasis 1 Malnutrition 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Depressive Disorder, Major 1 Depression 1 Body Weight 1 Anorexia Nervosa with Significantly Low Body Weight 1 Advanced Cancer 1

Interventions

pembrolizumab 134 Gemcitabine 121 Capecitabine 113 Fluorouracil 105 Paclitaxel 103 Bevacizumab 95 Oxaliplatin 94 Nivolumab 90 Leucovorin 87 Docetaxel 84 Radiosurgery 83 Irinotecan 77 Cisplatin 73 Carboplatin 73 Magnetic Resonance Spectroscopy 64 Cyclophosphamide 62 Cetuximab 62 Specimen Handling 56 Biopsy 55 Radiotherapy 52 Trastuzumab 51 Ipilimumab 45 Drug Therapy 45 Everolimus 41 Albumin-Bound Paclitaxel 39 130-nm albumin-bound paclitaxel 39 Pemetrexed 38 Fulvestrant 36 Doxorubicin 36 aldesleukin 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04763135 2023-06-08

MIR-P

Hospices Civils de Lyon

Phase 3 Terminated

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡